
Heska Corporation HSKA
Quartalsbericht 2023-Q1
hinzugefügt 05.05.2023
Heska Corporation EV/EBITDA 2011-2026 | HSKA
EV/EBITDA Jährlich Heska Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 141 | 444 | 137 | 83.9 | 23.9 | 25.2 | 18.6 | 17 | 41.4 | 10.8 | 6.29 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 444 | 6.29 | 86.2 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
27.4 | $ 117.5 | 2.1 % | $ 35.7 B | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
-100 | $ 16.83 | 4.86 % | $ 897 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
-6.02 | $ 2.2 | -4.35 % | $ 9.73 M | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 1.45 | 5.84 % | $ 1.93 M | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 23.53 | 1.73 % | $ 654 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
22 | $ 178.34 | 1.53 % | $ 8.84 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 4.59 | 5.52 % | $ 425 M | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 501.23 | 1.56 % | $ 14.5 B | ||
|
NeoGenomics
NEO
|
-33.5 | $ 8.0 | 4.03 % | $ 1.02 B | ||
|
Danaher Corporation
DHR
|
20.1 | $ 195.87 | 3.3 % | $ 140 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
70.5 | $ 126.96 | 4.99 % | $ 20.2 B | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 15.3 | 6.03 % | $ 463 M | ||
|
Senseonics Holdings
SENS
|
-13.8 | $ 6.72 | 0.6 % | $ 280 M | ||
|
Guardant Health
GH
|
-28.8 | $ 82.21 | 4.59 % | $ 10.3 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-2.25 | $ 2.85 | 5.95 % | $ 92.5 K | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.08 | -2.8 % | $ 4.78 M | ||
|
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
55.6 | $ 28.55 | 0.87 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 110.37 | 3.33 % | $ 9.1 B | ||
|
Soleno Therapeutics
SLNO
|
0.12 | $ 52.64 | 0.02 % | $ 2.68 B | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 264.18 | 1.25 % | $ 22 B | ||
|
Natera
NTRA
|
-19.5 | $ 201.9 | 4.6 % | $ 19.9 B | ||
|
Celcuity
CELC
|
-2.38 | $ 120.4 | 2.78 % | $ 5.63 B | ||
|
Neuronetics
STIM
|
-1.45 | $ 1.39 | 2.96 % | $ 91.7 M | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 81.67 | 1.34 % | $ 5.51 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 192.91 | 0.73 % | $ 21.4 B | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 9.14 | -2.97 % | $ 1.98 B | ||
|
ENDRA Life Sciences
NDRA
|
0.831 | $ 5.19 | 5.06 % | $ 4.08 M | ||
|
Organovo Holdings
ONVO
|
0.992 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
0.274 | - | -16.95 % | $ 1.54 M |